Cargando…
Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy
Fibrotic diseases pose significant clinical challenges due to their broadness and complexity. Thus, a better understanding of fibrogenesis and the development of more effective treatments is imperative. Recent evidence suggests a significant antifibrotic potential of an endogenous glycoprotein, endo...
Autores principales: | Zhang, Zequn, Liu, Xi, Shen, Zhaolong, Quan, Jun, Lin, Changwei, Li, Xiaorong, Hu, Gui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491667/ https://www.ncbi.nlm.nih.gov/pubmed/34595978 http://dx.doi.org/10.1080/10717544.2021.1983071 |
Ejemplares similares
-
Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer
por: Liu, Xi, et al.
Publicado: (2022) -
Anti-tumor therapy with macroencapsulated endostatin producer cells
por: Rodrigues, Danielle B, et al.
Publicado: (2010) -
Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
por: Wan, Yun-Yan, et al.
Publicado: (2013) -
Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies
por: Méndez-Valdés, Gabriel, et al.
Publicado: (2023) -
Endostatin is a potential inhibitor of Wnt signaling
por: Hanai, Jun-ichi, et al.
Publicado: (2002)